当前位置: 首页 > 详情页

The-980C/G polymorphism in APH-1A promoter confers risk of Alzheimer's disease

| 导出 | |

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Department of Neurology, Xuan Wu Hospital of the Capital Medical University, and Neurodegenerative Laboratory of Ministry of Education of the People’s Republic of China, Beijing, China [2]Department of Neurology, Barrow Neurological Institute, St. Joseph’s Hospital and Medical Center, Phoenix, AZ 85013, USA
出处:
ISSN:

关键词: Alzheimer's disease APH-1A gene polymorphism Yin Yang 1 gene expression gamma-secretase

摘要:
We previously described an association between Alzheimer's disease (AD) and a single-nucleotide polymorphism -980C/G (rs3754048) in the promoter of the anterior pharynx-defective-1a (APH-1A) gene. Here, we examine the potential of this -980C/G polymorphism to affect APH-1A transcription and confer a risk of AD. We validated the presence of APH-1A promoter polymorphism -980C/G in other two Chinese cohort sets (450 AD and 450 controls). Subsequently, we measured APH-1A mRNA and protein levels and gamma-secretase activity in C or G allele carriers. Finally, we examined the polymorphism's transcriptional function using a dual-luciferase reporter assay and also tracked transcription factor binding to the variant promoter sequence with electrophoretic mobility shift assays (EMSAs). We found that the APH-1A levels and gamma-secretase activity were higher in individuals carrying allele G. The G allele increased APH-1A transcriptional activity significantly in both N2A cells and HEK293 cells. The EMSA revealed an increased binding of the transcription factor Yin Yang 1 (YY1) to allele G. Overexpression of YY1 resulted in an activation of the APH-1A promoter (2.7-fold). Specific YY1 siRNA led to decreases in APH-1A promoter activity and mRNA and protein levels. Our data indicate that the APH-1A promoter polymorphism -980C/G might alter the binding ability of YY1 transcription factor, resulting in an increased level of APH-1A and gamma-secretase activity. These factors further facilitated beta-amyloid (Ab) 42 generation and ultimately modified patients' susceptibility to AD. The involvement of transcription factor YY1 might be a novel mechanism for the development of AD.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2010]版:
大类 | 2 区 生物
小类 | 1 区 老年医学 2 区 细胞生物学
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 老年医学 2 区 细胞生物学
JCR分区:
出版当年[2009]版:
Q1 GERIATRICS & GERONTOLOGY Q1 CELL BIOLOGY
最新[2023]版:
Q1 CELL BIOLOGY Q1 GERIATRICS & GERONTOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2009版] 出版当年五年平均 出版前一年[2008版] 出版后一年[2010版]

第一作者:
第一作者机构: [1]Department of Neurology, Xuan Wu Hospital of the Capital Medical University, and Neurodegenerative Laboratory of Ministry of Education of the People’s Republic of China, Beijing, China
通讯作者:
通讯机构: [*]Department of Neurology, Xuan Wu Hospital of the Capital Medical University, Beijing 100053, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:17236 今日访问量:0 总访问量:925 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院